Sichuan Biokin Stock Soars 10.17%, Hits Intraday High of CNY 285.00

Sichuan Biokin Pharmaceutical Co., Ltd. has experienced a significant surge in its stock price, gaining 10.17% on March 10, 2026. The stock reached an intraday high of CNY 285.00, reflecting strong activity in the market. This performance stands in stark contrast to the China Shanghai Composite, which only saw a modest increase of 0.65% on the same day. Over the past week, Sichuan Biokin has shown a robust performance with a 13.61% increase, while the broader market remained nearly flat with a 0.01% change. However, the company's one-month performance indicates a decline of 2.43%, highlighting some volatility in the short term. Despite these fluctuations, Sichuan Biokin has demonstrated impressive long-term growth, with a remarkable 343.08% increase over the past three years, significantly outperforming the China Shanghai Composite's 27.65% growth during the same period. The company's market capitalization stands at CNY 29,530 million, positioning it firmly within the large-cap segment of the pharmaceuticals and biotechnology industry.